Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

BAJAJ HEALTHCARE LTD.

NSE : BAJAJHCAREBSE : 539872ISIN CODE : INE411U01027Industry : Pharmaceuticals & DrugsHouse : Private

BSE690.8052.35 (+8.2 %)

PREV CLOSE ( ) 638.45

OPEN PRICE ( ) 642.35

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 74348

TODAY'S LOW / HIGH ( )613.00 698.00

52 WK LOW / HIGH ( )265 698

NSE689.1550.65 (+7.93 %)

PREV CLOSE( ) 638.50

OPEN PRICE ( ) 636.95

BID PRICE (QTY) 689.15 (122)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 917161

TODAY'S LOW / HIGH( ) 611.00 699.00

52 WK LOW / HIGH ( )263.3 699

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 15-07 1993

Management Info

Sajankumar Rameshwarlal Bajaj - Chairman Sajankumar Rameshwarlal Bajaj - Managing Director

Registered Office

Address 602-606, Bhoomi Velocity Infotech Park,Plot No. B-39, B-39/ A, B-39 A/1, Road No. 23,Wagle Industrial Estate, Thane (West),
Thane Dist,
Maharashtra-401604

Phone 022 6617400 / 401

Email bajajhealth@bajajhealth.com

Website www.bajajhealth.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,L B S Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

30Jan Bajaj Healthcare gets nod for manufact
Bajaj Healthcare has received approval from the Drug Controller General..

30Jan Bajaj Healthcare moves higher on getti
Bajaj Healthcare is currently trading at Rs. 679.35, up by 22.95 points..

30Jan Bajaj Healthcare informs about disclo
Bajaj Healthcare has informed that the company has received an approval..

17Jan Bajaj Healthcare gets exclusive rights
Bajaj Healthcare has received exclusive rights for manufacturing, distri..

17Jan Bajaj Healthcare trades jubilantly on
Bajaj Healthcare is currently trading at Rs. 637.45, up by 75.55 points..

Financials

Rs. in Millions

	QTR Sep 24	ANNUAL 24
Net Profit	94.64	-837.94
Gross Profit	124.48	-166.77
Operating Profit	271.3	849.51
Net Sales	1330.89	4734.18

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE) 7441.40 (2.96%)	M.Cap ( in Cr)18603.50
Wockhardt (BSE) 1557.15 (10.00%)	M.Cap ( in Cr)25299.38
Medplus Health Servi (BSE) 787.20 (8.64%)	M.Cap ( in Cr)9422.30
Suven Pharma (BSE) 1108.25 (4.99%)	M.Cap ( in Cr)28212.16
Divi's Lab (BSE) 5622.30 (0.83%)	M.Cap ( in Cr)149254.40

Shareholding Pattern

	PROMOTERS	59.19%
	NON-INSTITUTION	37.45%
	MUTUAL FUNDS/UTI	1.64%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
HDFC Pharma and Hea...	1.77

Risk Disclosures on Derivatives

Smart Quotes

BAJAJ HEALTHCARE LTD.